Educational Activities Archives

Filter by Target Audience Information
Filter by Target Audience

Please select the option that best aligns with your profession.

Target Audience
Filter by Topic Information
Filter by Topic

Please select the option that best aligns with your topic of interest.

Click on the plus (+) icon to display subtopics.

Filter by Format Information
Filter by Format

Please select the option that best aligns with your preferred format of training.

Formats
Key Term Search Information
Key Term Search

Use the search bar to enter in the title of a training, or other key terms.

Course and Resource Listing

Format: Webinar
Transitioning from jails and prisons back into the community can be especially difficult for people with opioid use disorders (OUD). Research suggests that opioid use overdose increases dramatically within the first 30 days of citizens returning to the community. Further, individuals recently released from incarceration face a risk of opioid overdose ten times greater than the general public. During these transitions it is critical that people receive seamless and appropriate resources in order to prevent overdose and return to use. This proper transition can help lower health care costs, hospitalizations and emergency department visits, as well as decrease mortality and recidivism for justice-involved individuals, yet at this time only 13 states have sought Medicaid waivers to provide SUD services pre-release. Join us today as we explore how programs can successfully develop services to ensure returning citizens receive appropriate care to address OUD.
Presenter(s):
Ed Hayes: Assistant Superintendent at Franklin County Sheriff’s Office, Administrative Director of the FCSO OTP and Rachel Katz, NP Director, Addiction Services, Friends of the Homeless (FOH), Medical Respite, CNP
Credit Available:
CE Credit(s): No
Certificate: Certificate of Attendance, 1-hour
Format: Clinical Tool
Psychiatric pharmacists are advanced practice clinical pharmacists committed to being part of an interdisciplinary team treating substance use disorders, often in combination with serious mental illness. The following SUD toolkits were developed to further the knowledge of pharmacists and other healthcare professionals.
Credit Available:
CE Credit(s): No
Certificate: No
Format: Clinical Tool
How should I monitor liver function tests in patients who are receiving naltrexone or extended-release naltrexone for their treatment of opioid and or alcohol use disorders? What should I do if a patient receiving naltrexone does develop evidence of a severe elevation of liver function tests or acute hepatitis?
Credit Available:
CE Credit(s): No
Certificate: No
Format: Clinical Tool
This manual provides guidance on the use of medication-assisted treatment for alcohol use misuse. It summarizes approved medications, screening and assessment, treatment planning, and patient monitoring.
Credit Available:
CE Credit(s): No
Certificate: No
Format: Podcast
Medication-assisted treatment is an important approach for some people with substance use disorders. It is also frequently misunderstood–isn’t treating someone with methadone for a heroin problem simply “trading one addiction for another?” Our guest, Dr. Frances Levin, will discuss this and other misconceptions regarding medication-assisted treatment.
Presenter(s):
Dr. Frances Levin
Credit Available:
CE Credit(s): No
Certificate: No